Overview
BPC-157 — also written as BPC 157 or Body Protection Compound-157 — is a synthetic pentadecapeptide (15 amino acids) with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. The compound corresponds to a partial sequence derived from a larger protein originally characterized in mammalian gastric juice. It is studied as a research reagent in laboratory investigations of tissue research and peptide stability; it is not approved for human use in any jurisdiction.
Research Context
BPC-157 appears in the preclinical literature primarily in models of connective tissue research — tendon, ligament, and gastrointestinal mucosa investigations using rodent in-vivo preparations and cultured cell-line systems. Standard research methodologies include scratch-wound migration assays in fibroblast and endothelial monolayers, ELISA quantification of vascular growth factors in culture supernatants, and histological evaluation of tissue ultrastructure in ex-vivo preparations. The peptide’s published profile of stability in acidic environments — it survives gastric juice intact, a property that destroys most peptide structures — has also driven its adoption as a benchmark reference in peptide stability research.
Mechanism Summary (Research Framing)
Published research literature characterizes BPC-157 in interactions with several signaling pathways relevant to tissue research: modulation of vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) expression in cultured cell preparations, interaction with the nitric oxide / endothelial nitric oxide synthase (NO/eNOS) system in vascular research models, and exploratory research on dopaminergic and serotonergic pathway interactions in rodent in-vivo preparations. The mechanistic understanding of BPC-157 remains active across multiple investigative directions in the published literature.
Storage Parameters
Lyophilized BPC-157 is stable for 24 months or longer when stored at −20°C in its sealed vial, protected from light and moisture. Brief room-temperature shipping exposure does not compromise integrity. Reconstituted aqueous solutions must be kept refrigerated and used within the validated stability window for the specific assay; aliquot before freezing to avoid repeated freeze-thaw cycles. Detailed COA and lot-specific stability information accompanies each Solira vial. See how Solira verifies every lot →
Related Research Compounds
- TB-500 — Thymosin Beta-4 fragment, frequently studied alongside BPC-157
- BPC-157 vs. TB-500 comparison — structural and research-pathway differences
- GHK-Cu — copper tripeptide, the third component of the GLOW Stack research blend
